治疗性血管新生在心肌梗死后的应用进展

    Progress in application of therapeutic angiogenesis after myocardial infarction

    • 摘要: 心肌梗死(MI)是一种急性缺血性心脏病,其病理特点是各种原因引起的心肌血管狭窄和堵塞,可并发心律失常、休克和心力衰竭,严重时危及患者生命。因此,促血管新生成为治疗MI的有效方法之一。近年来,随着对血管生长因子和血管新生研究的不断深入,治疗性血管新生已成为MI后治疗研究的新领域,在恢复血运重建方面起到重要作用。治疗性血管新生的方法主要包括蛋白质治疗、基因治疗和细胞治疗。本文就治疗性血管新生在MI后的应用做一综述。

       

      Abstract: Myocardial infarction is an acute ischemic heart disease that can be complicated by arrhythmia, shock and heart failure. In severe cases, it will endanger the lives of patients. Its pathological features are myocardial vascular stenosis and blockage caused by various reasons, which will lead to myocardial infarction. Angiogenesis is one of the effective methods for the treatment of myocardial infarction. In recent years, with research on angiogenic factors and angiogenesis, therapeutic angiogenesis has become a new research field of post-myocardial treatment and plays an important role in restoring revascularization. Methods for therapeutic angiogenesis include protein therapy, gene therapy and cell therapy. This article reviews the application of therapeutic angiogenesis after myocardial infarction.

       

    /

    返回文章
    返回